Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Country:  U.S.A.
Treatment/Intervention:  nutritional therapy
Results 1-25 of 55 for your search:
Start Over
OPT-821 with Vaccine Therapy and Beta-Glucan in Treating Younger Patients with High-Risk Neuroblastoma
Phase: Phase II, Phase I
Type: Treatment
Age: 21 and under
Trial IDs: 05-075, NCI-2009-01362, NCT00911560
The Effects of Ginseng on Cancer-Related Fatigue
Phase: Phase II, Phase I
Type: Supportive care
Age: 18 and over
Trial IDs: 2009-0854, NCI-2011-01127, NCT01375114
Ascorbic Acid, Gemcitabine Hydrochloride, and Erlotinib Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer
Phase: Phase II
Type: Treatment
Age: 18 to 75
Trial IDs: 11D.365, NCI-2012-00340, 2008-52(1), NCT01555489
Fish Oil in Preventing Colorectal Cancer in Participants Previously Diagnosed with Colon Polyps
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 40 to 79
Trial IDs: VICC GI 14138, NCI-2015-00480, 11165, GI 14138, NCI-2015-00070, NCT01661764
Curcumin in Reducing Fatigue in Patients with Chemotherapy-Treated Breast Cancer Undergoing Radiotherapy
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Over 18
Trial IDs: WINSHIP2139-11, NCI-2014-02195, NCT01740323
Carbohydrate-Restricted Diet in Treating Patients with Previously Treated Prostate Cancer
Phase: Phase II
Type: Treatment
Age: 20 and over
Trial IDs: Pro00041857, NCI-2013-00581, 00041857, Amd020_Pro00041857, NCT01763944
Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients with Breast or Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 19 and over
Trial IDs: 0S-10-3, NCI-2013-00414, HS-11-00231, NCT01802346
Calcitriol before Surgery in Preventing Calcium Loss in Patients Undergoing Thyroidectomy
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: TC-P2-CALCITRIOL, NCI-2014-00962, NCT01868750
Omega-3 Fatty Acid in Treating Patients with Stage I-III Breast Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CCCWFU 98113, NCI-2013-00963, NCT01869764
Green Tea Extract in Treating Patients with Low-Risk Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 45 to 85
Trial IDs: CASE 6812, NCI-2013-01372, NCT01928485
Pomegranate-Extract Pill in Preventing Tumor Growth in Patients with Localized Prostate Cancer Undergoing Active Surveillance
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 21 and over
Trial IDs: CO11378, NCI-2014-00695, N01-CN-2012-00033, UWI2013-00-01, NCT02095145
Curcumin and Cholecalciferol in Treating Patients with Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CASE 5913, NCI-2014-00266, NCT02100423
Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer
Phase: Phase II
Type: Prevention
Age: 50 to 80
Trial IDs: 13-000432, NCI-2014-01257, NCT02176902
Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GHNSCLC-2 001, NCI-2014-02209, NCT02047344
High-Dose Ascorbic Acid in Treating Patients with Stage IIIB-IV Non-small Cell Lung Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 201412760, NCI-2015-00709, NCT02420314
Low Calorie Diet in Reducing Side Effects in Patients Undergoing Liver Surgery
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: D12052, NCI-2012-01251, NCT01645852
Donor Stem Cell Transplant after Busulfan and Fludarabine Phosphate with or without Anti-thymocyte Globulin in Treating Patients with Inherited Metabolic Disorders, Severe Osteopetrosis, or Rett Syndrome
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 55 and under
Trial IDs: 2013LS104, NCI-2014-02309, 1406M51542, MT2013-31, NCT02171104
Low-Sugar Diet in Treating Patients With Stage II-III Pancreatic Cancer Undergoing Chemoradiation Therapy
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 201102772, NCI-2012-00326, 01110101, NCT01419483
Ketogenic Diet in Treating Patients With Stage III-IV Non-Small Cell Lung Cancer Undergoing Chemoradiation
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 201102773, NCI-2012-00327, 02110110, NCT01419587
IH636 Grape Seed Proanthocyanidin Extract and Cholecalciferol in Reducing Inflammation in Patients with Advanced Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 21 and over
Trial IDs: MUSC CTO 101839, NCI-2013-00692, 101839, MS13_Pro00020929, Pro00020929, NCT01820299
Gemcitabine Hydrochloride, Ascorbic Acid, and Radiation Therapy in Treating Patients with Pancreatic Cancer That Cannot Be Removed by Surgery
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 201310772, NCI-2014-00824, GAX-PAN-I, NCT01852890
Curcumin and Irinotecan Hydrochloride in Treating Patients with Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: LCCC 1227, NCI-2013-02089, 13-1052, NCT01859858
Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue from Patients With Prostate Cancer Undergoing Surgery
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Age: 40 to 75
Trial IDs: 12-000886, NCI-2013-01153, 12-000886-AM-00002, P30CA016042, R03CA171583, NCT01912820
Start Over